drugset / Trial / NCT06825416
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.
Timeline
- Start
- 2025-03-16
- Primary completion
- 2026-02-15
- Completion
- 2026-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | — | — |
| Subject | SHR-2004 | Monoclonal antibody | — | — |
Indications
No indication recorded.